Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/SENSEI-BIOTHERAPEUTICS-IN-118558698/nieuws/Sensei-Biotherapeutics-Inc-kondigt-aan-dat-de-eerste-patient-is-gedoseerd-in-de-Fase-1-2-klinisch-44024036/?utm_source=whatsapp&utm_medium=social&utm_campaign=share